Navigation Links
Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
Date:12/10/2012

CRi),
  • The median duration of CRc was 7.0,weeks, which was likely impacted by a high percentage (37 percent) of patients who were bridged to a HSCT,
  • An additional 16 percent of patients achieved a PR,
  • Of those refractory to their last AML therapy, 48 percent achieved at least a PR with quizartinib,
  • The rate of HSCT after quizartinib use was 37 percent, which represents clinical benefit in this heavily pretreated patient population,  
  • The median overall survival was 25.6 weeks,
  • Ten patients (26 percent) are considered "long-term survivors" given they remained alive for more than 12 months
  • The most common treatment-emergent AEs were nausea (53 percent), vomiting (41 percent), febrile neutropenia (38 percent), diarrhea (37 percent), anemia (34 percent), QT interval prolongation (27 percent) and fatigue (24 percent).  QT interval prolongations were asymptomatic, transient, and there were no Grade 4 events or deaths associated with QT prolongation. A total of 25 patients (18 percent) experienced an AE resulting in discontinuation of quizartinib, with the most common AE leading to discontinuation being progressive disease.
  • Overall, responses (CRc) were achieved in 46 percent of heavily pretreated patients with the FLT3-ITD mutation. These responses are clinically meaningful given they allowed a high percentage (37 percent) of  patients to be bridged to a stem cell transplant, and 23 percent of the FLT3-ITD positive patients remained alive for more than 12 months (of which 61 percent received a HSCT). The potential impact of bridge to HSCT was shown in the median overall survival for patients with the FLT3-ITD mutation which was 33.3 weeks for those who had a subsequent HSCT, compared to 17.7 weeks in those patients with the FLT3-ITD mutation who did not receive a subsequent HSCT.  Nearly one-in-three patients without the FLT3-ITD mutation also responded to qui
    '/>"/>

  • SOURCE Ambit Biosciences
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
    2. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
    3. Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus Extended Release Capsules
    4. Personal Connections Drive Employee Participation For Changing Tomorrow Day at Astellas
    5. Astellas to Close Urogenix, North Carolina-based Urology Research Facility
    6. Astellas and Fujita Health University Discover Neuronal Maturation Deficits in Patients Suffering from Schizophrenia and Bipolar Disorder
    7. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
    8. Xstelos Holdings Announces Dividend
    9. Medbox, Inc. Announced Increased Funding for Corporate Giving Program in 2013
    10. Biogen Idec and Isis Pharmaceuticals Announce Collaboration For Antisense Programs To Treat Neurological Disorders
    11. IRIDEX Corporation Announces Preliminary Results of its Tender Offer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/20/2014)... YORK and RALEIGH, N.C., Oct. 20, 2014 ... Hereditary Neuropathy Foundation (HNF), both philanthropies, announced today ... drug candidates for the treatment of the rare ... BioPontis Alliance announced its alliance model earlier ... a first demonstration of a collaborative model where ...
    (Date:10/19/2014)... , Deutschland, October 19, 2014 ... gefragt. Das Problem dabei ist, dass ... mit der Kompetenz zu teilen. Es ... deshalb freuen wir uns umso mehr, dass es ... ihre Gepflogenheiten bei Kühlketten aufzuschreiben - mit einem ...
    (Date:10/17/2014)... , Oct. 17, 2014  Hanger, Inc. (NYSE: ... report its results of operations for the quarter ended ... the market closes.  A conference call to discuss these ... on Friday, November 7, 2014. Those wishing to participate ... Friday, November 14, 2014 by dialing 1-855-859-2056 and referencing ...
    Breaking Medicine Technology:The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 2The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 3Vergleichsbericht zu Pharma-Kühlketten und CRT 2
    ... Oct. 14 PDR Network, the largest distributor ... Risk Evaluation and Mitigation Strategy ("REMS") program alerts, ... largest professional medical liability carrier, to provide physicians ... of REMS CME programs. Physician participation in FDA-mandated ...
    ... 14 The Food and Drug Administration says ... to treat everything from autism to Alzheimer,s disease—can ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo: ... the agency warned eight companies that making unsubstantiated ...
    Cached Medicine Technology:PDR Network and The Doctors Company Deliver CME Into REMS 2PDR Network and The Doctors Company Deliver CME Into REMS 3
    (Date:10/20/2014)... Columbus, OH (PRWEB) October 20, 2014 National ... Ohio Chapter of the American Academy of Pediatrics (Ohio AAP, ... Administration (NHTSA) in encouraging parents of teen drivers to talk ... hit the road. , Motor vehicle crashes are the leading ... 2,055 teen drivers involved in fatal crashes, and 859 (42%) ...
    (Date:10/20/2014)... (PRWEB) October 20, 2014 Punzoné , ... in the U.S., has a lot to celebrate this month. ... country recognizes the achievements and contributions of Americans of Italian ... for Punzoné, and today it shares its favorite Italian cocktails ... trip to Italy - even if it is only in ...
    (Date:10/19/2014)... October 20, 2014 The leading ... ( http://www.top10bestseohosting.com/go/iPage/ ) and GreenGeeks are the best ... platforms for those who want to buy high ... time. , The IT manager of Top10BestSEOHosting.com says, ... most recommended suppliers for everyone. A lot of ...
    (Date:10/19/2014)... 2014 Having been working in the garment ... of customer needs. According to James, one of the company’s ... sequins, or with high-low skirts that add beauty to them. ... Recently, LunaDress has unveiled its new selection of 2014 long ... company’s brand new items are available in over 20 popular ...
    (Date:10/19/2014)... 19, 2014 Visual Impact Frequency ... just been released to the public generating a ... building and fitness community. The commotion surrounding the ... Vin Delmonico prompting an investigative review. , "Many ... what is commonly known as a training 'plateau' ...
    Breaking Medicine News(10 mins):Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 4Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2Health News:Visual Impact Frequency Training Review: Rusty Moore's Latest Fitness Guide Released 2
    ... a San Francisco Bay Area nonprofit, has been chosen as ... inaugural marathon and 1/2 marathon on June 27, 2009. Becoming ... country can train and prepare for the event and raise ... face of cancer."We are proud to have the honor of ...
    ... Founder Zac Workman proudly touts support of Sam Schmidt Paralysis ... While Punch Energy Drink,s well-recognized tagline may be "changing the ... beverage industry phenom, is equally focused on changing the world ... , , In a joint press conference today, ...
    ... Health -- a new suite of affordable healthcare discounts programs that ... out-of-pocket healthcare costs. Reassurance Health offers seven individual and family ... care, and flat-rate reimbursement for doctor visits. , ... ...
    ... to Cancer Patients in HELIOS HospitalsBERLIN, March 10 ... will gain access to the most modern radiotherapy treatments ... it is acquiring nine linear accelerators from Varian Medical ... them equipped with RapidArc(TM) technology for fast and comfortable ...
    ... Peripheral Vascular Treatment Market to Grow to $4.7 BillionVANCOUVER, ... international medical device & dental market research firm, an ... lower-limb Peripheral Arterial Disease (PAD), with less than 20% ... increases and more patients seek treatment, the U.S. market ...
    ... 10 InPlace Medical Solutions recently completed ... healthcare services for Scorpion Offshore Inc.,s ultra-premium ... project makes Scorpion Offshore the first drilling ... full-service system of advanced healthcare, direct physician ...
    Cached Medicine News:Health News:Lazarex Cancer Foundation Chosen as an Official Charity of Inaugural Rock 'N' Roll Marathon in Seattle 2Health News:Punch Energy Drink Announces Recipient of Its Inaugural LIVE BETTER AWARD(R) 2Health News:Punch Energy Drink Announces Recipient of Its Inaugural LIVE BETTER AWARD(R) 3Health News:As Layoffs Increase Nationally, Atlanta's Coverdell Launches Suite of Healthcare Discount Programs; Saving Consumers Up to 60 Percent on Healthcare Spending 2Health News:As Layoffs Increase Nationally, Atlanta's Coverdell Launches Suite of Healthcare Discount Programs; Saving Consumers Up to 60 Percent on Healthcare Spending 3Health News:As Layoffs Increase Nationally, Atlanta's Coverdell Launches Suite of Healthcare Discount Programs; Saving Consumers Up to 60 Percent on Healthcare Spending 4Health News:Leading German Healthcare Group Selects Equipment and Software from Varian Medical Systems for Major Replacement Project 2Health News:Study Shows 80% of Adults with Peripheral Arterial Disease Go Undiagnosed 2Health News:Scorpion Offshore Inc. Pilot Project With InPlace Medical Solutions Sets New Standard for Offshore Medical Services 2Health News:Scorpion Offshore Inc. Pilot Project With InPlace Medical Solutions Sets New Standard for Offshore Medical Services 3
    ... a surgical approach to glaucoma management that ... The ciliary body (which produces aqueous humour) ... anterior or posterior segment, through the endoscope ... easily and accurately identified utilizing endoscopy. This ...
    ... Endoscopic CycloPhotocoagulation (ECP) is a surgical ... endoscopy and visualized laser application. The ciliary ... by the surgeon, from the anterior or ... time. The target tissues are easily and ...
    ... surgical approach to glaucoma management that employs ... ciliary body (which produces aqueous humour) is ... or posterior segment, through the endoscope in ... and accurately identified utilizing endoscopy. This allows ...
    ... a surgical approach to glaucoma management that ... The ciliary body (which produces aqueous humour) ... anterior or posterior segment, through the endoscope ... easily and accurately identified utilizing endoscopy. This ...
    Medicine Products: